TOP-CABG Trial: Follow-up Extension (TOP-CABG FE)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
To further evaluate the long-term effects of the two antiplatelet strategies on saphenous vein graft patency, long-term adverse cardiovascular events, and bleeding events after coronary artery bypass grafting (CABG), we plan to conduct an extended follow-up study based on the previously completed TOP-CABG trial. This extended follow-up aims to provide high-quality evidence to inform more optimized and individualized long-term antiplatelet management strategies for patients after CABG.
Epistemonikos ID: e7ad3aee166e3c229f97e2e31cec1aac6fdb60c0
First added on: Oct 14, 2026